Skip to main content
. 2022 Apr 27;94:107125. doi: 10.1016/j.ijscr.2022.107125

Fig. 2.

Fig. 2

PET-CT 3 months after discontinuation of pembrolizumab

(a) The uterus (white arrow) and (b) para-aortic lymph node metastases (white arrow) showed high FDG uptake.

PET-CT: positron emission tomography-computed tomography; FDG: fluorodeoxyglucose.